Ann Weinacker

Clinical Focus

• Critical Care Medicine
• Pulmonary Disease
• Pulmonology (Lung) and Critical Care

Administrative Appointments

• Associate Director, Intensive Care Unit, Stanford University Medical Center (1999 - present)
• Continuing Quality Improvement in the ICU Committee, Stanford University School of Medicine (2003 - present)
• Chair, Emergency Medical Response Team Committee, Stanford University Medical Center (2007 - present)
• Vice Chair, Clinical Affairs, Department of Medicine, Stanford University (2007 - 2008)
• Dean's Task Force for Clinical Excellence, Stanford University School of Medicine (2007 - 2008)
View All 9administrative appointments of Ann Weinacker

Honors and Awards

• Denise O'Leary Award for Clinical Excellence, Stanford Hospital and Clinics Board of Directors (2008)
• Excellence in Teaching, Stanford University School of Medicine (2004)
• Chief Residents' Teaching Award, Stanford School of Medicine (2003)
• Leadership Development in Pulmonary & Critical Care Medicine, American College of Chest Physicians (1999)
• Victor Benator Award for Best Teaching Resident, University of South Alabama (1989)

Professional Education

Graduate & Fellowship Program Affiliations

• Anesthesia

Research Interests

Dr. Weinacker's research interests center around ICU outcomes. Her specific interests include venous thromboembolism, acute respiratory distress syndrome, sepsis, and the use of echocardiography in the ICU. In addition to ongoing research in each of these areas, Dr. Weinacker teaches a course with Dr. David Liang (cardiology) on the use of portable echocardiography to evaluate hemodynamic instability in critically ill patients.

Publications

• Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Christie JD, Shah CV, Kawut SM, Mangalmurti N, Lederer DJ, Sonett JR, Ahya VN, Palmer SM, Wille K, Lama V, Shah PD, Shah A, Weinacker A, Deutschman CS, Kohl BA, Demissie E, Bellamy S, Ware LB. Am J Respir Crit Care Med. 2009; 180 (10): 1010-5
• Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Hoffman SA, Wang L, Shah CV, Ahya VN, Pochettino A, Olthoff K, Shaked A, Wille K, Lama VN, Milstone A, Ware LB, Orens J, Weinacker A, Demissie E, Bellamy S, Kawut SM, Hancock WW, Christie JD. Am J Transplant. 2009; 9 (2): 389-96
• Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation. Kawut SM, Okun J, Shimbo D, Lederer DJ, De Andrade J, Lama V, Shah A, Milstone A, Ware LB, Weinacker A, Demissie E, Christie JD. Chest. 2009; 136 (1): 237-44
• Randomized clinical trial of activated protein C for the treatment of acute lung injury. Liu KD, Levitt J, Zhuo H, Kallet RH, Brady S, Steingrub J, Tidswell M, Siegel MD, Soto G, Peterson MW, Chesnutt MS, Phillips C, Weinacker A, Thompson BT, Eisner MD, Matthay MA. Am J Respir Crit Care Med. 2008; 178 (6): 618-23
• Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Covarrubias M, Ware LB, Kawut SM, De Andrade J, Milstone A, Weinacker A, Orens J, Lama V, Wille K, Bellamy S, Shah C, Demissie E, Christie JD. Am J Transplant. 2007; 7 (11): 2573-8